Abstract: The aim of the present study was to evaluate the association between metabolic syndrome (MS) and periodontitis (PD), through a systematic review and meta-analysis. Original observational studies assessing the association between MS and PD in adults, published before May 11 th (2017), were identified through electronic searches of MEDLINE, EMBASE and Cochrane Library databases. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guideline was used. For studies to be included, they had to mention the criteria used to diagnose MS and to have used at least one clinical measure to diagnose PD. There was no language restriction. Three reviewers independently identified eligible studies for possible inclusion in the systematic review and meta-analysis. The quality of the studies was evaluated by the Newcastle-Ottawa scale for observational studies. A random model meta-analysis was conducted. The strategies used to investigate heterogeneity were sequential analysis, subgroup analysis, univariate meta-regression and sensitivity analysis. Thirty-three studies met the inclusion criteria for the systematic review, and 26 had enough information to be included in the meta-analysis, totaling 52,504 patients. MS and PD were associated with an odds ratio of 1.38 (95%CI 1.26-1.51; I2 = 92.7%; p < 0.001). Subgroup analysis showed that complete periodontal examination (I2 = 70.6%; p < 0.001) partially explained the variability between studies. The present findings suggest an association between MS and PD. Individuals with MS are 38% more likely to present PD than individuals without this condition. Prospective studies should be conducted to establish cause and effect relations between MS and PD.
Marta Liliana MUSSKOPF (b) Marina MENDEZ (a) Luciana Loss Reck REMONTI (c) Cristiane Bauermann LEITÃO (c) Jorge Luiz GROSS (c) Patricia WEIDLICH (a) Rui Vicente OPPERMANN (a) Introduction Periodontitis (PD) is a bacteria-induced chronic inflammatory disease, which destroys the bone and connective tissue that support the teeth. It is estimated that approximately 20 to 60% of the world's population may have some degree of destructive periodontal disease, 1, 2, 3, 4 and that 7.4%, representing 538 million individuals, have more severe forms. 5 The condition is generally diagnosed by a clinical dental examination, since such signs and symptoms as dental mobility, halitosis, altered tooth positioning and frequent abscesses tend to be noticed by patients only in the final stages of the disease. Patients presenting moderate and severe PD have been found to produce higher systemic levels of inflammatory and immune markers, such as C-reactive protein, interleukin-6, interleukin 1β and tumoral necrosis factor (TNF). 6, 7 PD treatment is able to reduce these markers. 8 The low-grade inflammatory status induced by untreated PD creates a systemic inflammatory phenotype that has been associated with several other systemic diseases/disorders, including cardiovascular diseases, 9 obesity, 10 insulin resistance 11 and metabolic syndrome (MS). 12, 13, 14, 15, 16 MS consists of a group of metabolic abnormalities associated with the greater likelihood of developing type 2 diabetes and cardiovascular disease. 17 According to the most recent guidelines issued in 2009 by the International Diabetes Federation (IDF) and the American Heart Association/ National Heart, Lung and Blood Institute (AHA/NHLBI), MS is defined as the combination of the following conditions: increased plasma glucose, hypertension, hypertriglyceridemia, low HDL cholesterol and/or elevated abdominal circumference. 18 Patients must have at least three of these abnormalities to be diagnosed with MS. Its prevalence varies according to the population studied and the criteria used for diagnosis; however, it is estimated that a quarter of the world population has MS. The risk of developing this condition is thought to increase proportionally with age. 19 The association between MS and PD has become an important topic of research in the scientific literature. The presence of continuous low-grade inflammatory status could lead to the development of insulin resistance and upset the balance of interactions between cytokines and the periodontium. 17, 19 PD may also influence one's general health status by affecting the host's susceptibility to systemic diseases resulting from the accumulation of gram-negative bacteria and inflammatory mediators in the bloodstream, both of which lead to inflammation.
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These features also characterize MS. 17, 19, 20 The results of the studies that evaluated the relation between PD and MS are widely discrepant. 12, 13, 14, 15, 16, 21, 22, 23 Considering that this relationship is characterized differently by conflicting findings, there is still no consensus on the magnitude of the association between MS and PD. Since systematic reviews are important tools to reconcile these seemingly divergent findings, the aim of the present study was to assess the association between MS and PD through a systematic review and meta-analysis of observational studies.
Methodology Focused question
Is there an association between metabolic syndrome and periodontal disease demonstrated in observational studies? The PECO strategy for the research question was: in patients diagnosed with periodontal disease and/or metabolic syndrome, the exposure was the presence of PD and/or MS, compared with patients with no PD and/or no MS. The outcome was any measure of prevalence of PD and MS.
Search strategy
The authors undertook a systematic review to locate original studies on the association between PD and MS. The study protocol was approved by the Research Committee of UFRGS (Study 22842). Observational studies were identified, focusing on participants diagnosed with PD and MS. The outcome was PD and/ or MS, since cross-sectional studies have no temporal component, and do not allow both directions of the association to be investigated. The present systematic review was conducted based on guidelines established for meta-analyses of observational studies 24 and is presented according to the PRISMA Statement.
Electronic databases were systematically searched for scientific articles published before May 11 th , 2017, which evaluated the association between MS and PD. The search was conducted in MEDLINE (accessed via PubMed), EMBASE and the Cochrane Library, and used the following keywords and MeSH terms (*): periodontal attachment loss* OR periodontics* OR gingivitis* OR periodontal diseases* OR gingival bleeding OR periodontitis* AND metabolic syndrome x* OR metabolic syndrome OR syndrome x OR plurimetabolic. There was no language restriction. Articles in Chinese, Polish and Persian were translated with online translation software.
Relevant unpublished studies were located by reviewing abstracts in the annals of main scientific events in the field since 2006. Two reviewers (MLM and MM) independently identified eligible studies for possible inclusion in the systematic review and meta-analysis, based on their titles and abstracts. The articles whose abstracts were selected were retrieved for full text evaluation. The studies selected for detailed analysis by these two investigators (MLM and MM) had a kappa agreement of 0.95. Disagreements were settled by a third investigator (RVO).
Studies were considered eligible when meeting the following criteria: original epidemiological study, observational, cross-sectional, case-control, or cohort design, adult sample, use of at least one clinical diagnostic criterion for PD that was clearly defined to warrant reproducibility, and clearly defined criteria for the diagnosis of MS. The studies excluded from the analysis, and the reasons for their exclusion, are reported in Figure 1 .
Data extraction
The data were extracted independently by two investigators (MLM and PW), and included the participants' age, gender and smoking status, nature of the experimental design, the diagnostic criteria used for PD and MS, total number of participants, number of participants with PD and MS, and study outcomes.
Quality assessment
The quality of the studies was evaluated using the Newcastle-Ottawa scale 25 for observational studies. The scale assigns a score of zero to nine stars to each article, whereby a greater number of stars indicate a higher quality study. Figure 1 . Flowchart of the search for studies, their selection and inclusion.
Statistical analysis
The general effect size was calculated using the reported PD and MS prevalence rates. Baseline values were used for cohort and case-control studies. When these data were not available, the authors were contacted by email. Random effect models were used in the analyses to account for between-study variability. Four strategies were used to investigate heterogeneity, considered high whenever I 2 was greater than 50%.
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The first strategy involved univariate meta-regression, performed to assess the effect of age, gender and smoking status on estimates of heterogeneity. The second step involved successive removal of each study, so that its impact on I 2 values could be observed. In the third step, a subgroup analysis took into account the periodontal examination and the MS diagnosis criteria. The fourth and last step of the heterogeneity analysis involved the sensitivity analyses, which included only those studies that received scores of eight or nine stars on the Newcastle-Ottawa scale. 27 The possibility of publication bias was evaluated using a funnel plot of the effect size plotted against the standard error of each trial. Begg's and Egger's tests were used to evaluate funnel plot asymmetry, with significant publication bias defined as a p-value < 0.1. The analyses were performed using STATA software (version 12; Stata Corp, College Station, USA).
Results
The electronic search retrieved 290 articles from PubMed and EMBASE. No additional articles were found in the Cochrane Library or in any other database searched. Two hundred and thirty-seven studies were excluded based on titles and abstracts, resulting in 53 articles for full-text evaluation. A total of 33 studies met the eligibility criteria (29 cross-sectional, two case-control and two cohort studies, totalizing 52,504 participants; Figure 1 ) and were included in the systematic review, and 26 were included in the meta-analysis. Seven studies were not included in the meta-analysis, because there was no prevalence data for PD and/or MS. 28, 29, 30, 31, 32, 33, 34 Table 1 describes the studies included in the review. The articles were published between 2007 and 2017, and most were conducted in Asian countries. PD was diagnosed by a complete periodontal examination in seventeen studies, 12, 23, 28, 31, 32, 33, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45 a nd by a pa r t ia l per iodont a l exa m i n at ion in sixteen studies. 13, 14, 15, 16, 22, 29, 30, 34, 46, 47, 48, 49, 50, 51, 52, 53 Concerning the definition criteria for PD, eleven studies 12, 14, 15, 22, 29, 30, 34, 49, 50, 51, 52 used the Community Periodontal Index (CPI), 54 and seven studies 23, 37, 40, 42, 43, 45, 47 used the classification system proposed by Page and Eke. 55 The remaining fifteen studies established other diagnostic criteria for PD. 13, 16, 28, 31, 32, 33, 35, 36, 38, 39, 41, 44, 46, 48, 49 Thirteen studies diagnosed MS using the National Cholesterol Education Program -Adult Treatment Panel III (NCEP ATP III) criteria, 12, 13, 15, 16, 22, 23, 28, 32, 33, 37, 46, 49, 51 ten used the 2005 IDF criteria, 29, 30, 35, 38, 39, 40, 41, 42, 47, 48 four used both the IDF 2009 and AHA/NHBLI 2009 criteria, 14, 36, 50, 52 three used the IDF 2009 criteria 44, 45, 53 and three studies used other classification criteria. 31, 34, 43 (Figure 2 ). Meta-regression showed that age explained 22% of the heterogeneity of the results (p = 0.01), whereas gender (p = 0.09) and smoking status (p = 0.40) failed to explain heterogeneity. In addition, none of the studies in itself could explain the heterogeneity when rerunning the meta-analysis by excluding one study at a time. Subgroup analyses were conducted by dividing the studies according to periodontal examination (complete or partial) or by the criteria used to define MS. When PD was diagnosed by a complete dentition examination, an OR of 1.16 (95%CI 1.08 -1.25; I 2 = 70.6%) was obtained ( Figure 3 ). Studies that used a partial periodontal examination showed an OR of 1.58 (95%CI 1.38-1.82; I 2 = 90.8%). The magnitude of association between the two conditions, according to the MS criteria used, was 1.38 (95%CI (Figure 4 ). The authors also evaluated if study quality could be responsible for the heterogeneity observed. The evaluation of six studies with higher scores in the Newcastle-Ottawa quality assessment scale 16, 23, 37, 41, 42, 47 did not decrease the heterogeneity (I 2 = 81.4 %; p < 0.001). There was evidence of publication bias, as demonstrated by the funnel plot, Egger's regression test (p = 0.03) and Begg's test (p =0.005; Figure 5 ).
Discussion
The present findings suggest that individuals with MS are 38% more likely to have PD than individuals without this condition. This meta-analysis was associated with significant heterogeneity, which may be attributed to variability across the studies, in regard to PD diagnosis (complete vs. partial dental examination). Our results corroborate those of the single meta-analysis, which also assessed the association between MS and PD, and which reported an OR of . 21 The main limitation of this meta-analysis was the inclusion of studies with PD diagnosed by both clinical and radiographic methods. Considering that low-grade inflammatory status accounts for the biological plausibility of the relationship between MS and PD, the clinical examination should be preferred in this scenario, since the presence of inflammation in periodontal tissues cannot be assessed by radiologic methods. Four studies included in the previous systematic review 21 were not included in the present study, because they used radiographic methods for PD diagnosis, 56, 57 or lacked information regarding PD or MS diagnosis criteria. 58, 59 The authors considered this limitation and performed a subgroup analysis, dividing the studies into two categories: those with secure PD diagnosis, defined by the presence of severe PD defined both clinically and radiographically, and those with insecure PD diagnosis, and less severe or not well-defined cases in the original study.
Several studies in the literature have investigated the relationship between MS and PD. However, Figure 2 . Meta-analyses of the association between periodontal diseases and metabolic syndrome.
the results of these studies have been widely discrepant. Whereas a number of them have reported positive associations between these two conditions, 12, 13, 14, 15, 16, 21 other investigations have found no relationship between them 22, 23 . Reasons for the variability in results include differences in diagnostic criteria for PD and MS, the involvement of untrained examiners in diagnosing PD, the improper control of confounding factors and the presence of selection bias.
Our meta-analysis showed significant heterogeneity, which was explored by several methods. A decrease in heterogeneity was observed when only studies using complete dental examination were considered (I² for all studies: 92.7% and for complete dental examination: 70.6%), indicating that studies using complete periodontal examination presented more reliable estimates. The higher variability found in studies using partial dental examination (I² = 90.8%) may be attributed to erroneous diagnosis of these individuals. The extension and severity of PD should be assessed by a full six-site examination, considered the gold standard for PD. 60 Half of the studies conducted partial examinations, which are known to underestimate the prevalence of PD. 60 In addition to variability in the examination protocol used to diagnose PD, the criteria used to detect this condition differed across the studies. Eleven studies used CPI criteria to diagnose the disorder. The Community Periodontal Index of Treatment Needs (CPITN) 54 was initially developed to assess the treatment needs of patients with PD, and requires ten teeth to be checked for gingival bleeding, supra-and subgingival calculus and periodontal pockets (classified according to size, namely those measuring between 4 and 5 mm and those measuring 6mm or more). WHO recommendations were Daudt LD, Musskopf ML, Mendez M, Remonti LLR, Leitão CB, Gross JL et later amended to include the required measurement of periodontal attachment loss, leading to the renaming of the diagnostic index as CPI (Community Periodontal Index). Although the CPI was not initially designed for use in epidemiological studies, it is widely used in this type of research, although it has proved deficient in assessing the periodontal conditions of several populations reliably. 61 This low reliability may be attributed to its nature as a partial exam, and of investigating symptoms in a hierarchical sequence.
It is reasonable to think that different MS diagnostic criteria could account for the variability in the studies. For example, although the NCEP ATP III criteria are used by a number of studies, they do not account for population differences in body composition when defining abdominal circumference cut points. The existence of documented differences between the body composition of individuals of different ethnicities 62 requires population-specific visceral fat cut-offs to be established, as suggested by the IDF and AHA/NHBLI in 2005. 63 In fact, the 2009 guidelines set in consensus by these institutions established population-specific abdominal circumference cut points. 18, 19 NCEP ATP III criteria may underestimate the prevalence of MS in some populations, as has been found in some studies of Asian individuals 12, 15, 16, 49 for whom specific cut points were later recommended. 63, 64 However, the variability among studies was not explained by the different MS diagnostic criteria used in the present study.
In addition to investigating the association between PD and MS, some authors also studied the association between PD and specific features of MS. When analyzing the factors separately, the results ranged from the absence of an association to an adjusted OR up to 1.8 (95%CI 1.2-2.8) for elevated abdominal circumference, ) for low HDL cholesterol, ) for hypertension, for alterations in glucose homeostasis, 46 and a raw OR of 1.38 (95%CI 1.17-1.62) for hypertriglyceridemia. 15 Since these results are similar to those found for MS by these and other authors, 21 the discussion regarding the relevance of the syndrome persists. The issue of whether MS is more than a combination of its individual components remains controversial. 65 Nevertheless, treatment for one of these individual conditions could have an effect on the other, thus enhancing the treatment benefits and optimizing the effects of the intervention on the patient's health.
The nature of the present review, with the inclusion of mainly cross-sectional studies, may be considered a limitation of this meta-analysis, since no cause and effect relations could be established between the two conditions. It should also be acknowledged that unpublished studies and individual studies with quality limitations may still be relevant, despite the best efforts to conduct a broad search, and despite the lack of statistical evidence of bias.
Conclusion
In conclusion, considering its limitations, this systematic review with meta-analysis suggests an association between MS and PD. Further research in this field could include prospective studies conducted to establish cause and effect relations between these two conditions, and whether specific treatments could influence the development of both conditions. 
